In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biosensors Perked Up By Japan, China News, Profitability Successes

Executive Summary

CV and critical care company Biosensors is on the brink of a global top 100 medtech company sales ranking: in the first nine months of FY15, it made total sales of US$232.5 million, which would make a year-end total of over $300 million a prospect. Its longer-term strategy is to strengthen its position in the cardiovascular market, expand its geographical reach and add new product lines and investment opportunities to grow into a multi-platformed international player.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts